(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.23%.
Whitehawk Therapeutics's earnings in 2026 is -$20,596,000.On average, 7 Wall Street analysts forecast WHWK's earnings for 2026 to be -$61,331,935, with the lowest WHWK earnings forecast at -$76,316,844, and the highest WHWK earnings forecast at -$54,016,467.
In 2027, WHWK is forecast to generate -$60,539,033 in earnings, with the lowest earnings forecast at -$76,316,844 and the highest earnings forecast at -$45,591,881.